Studying Lung Cancer Cells from Pleural Effusions
Author Information
Author(s): Mancini Rita, Giarnieri Enrico, De Vitis Claudia, Malanga Donatella, Roscilli Giuseppe, Noto Alessia, Marra Emanuele, Laudanna Carmelo, Zoppoli Pietro, De Luca Pasquale, Affuso Andrea, Ruco Luigi, Di Napoli Arianna, Mesiti Giuseppe, Aurisicchio Luigi, Ricci Alberto, Mariotta Salvatore, Pisani Lara, Andreetti Claudio, Viglietto Giuseppe, Rendina Erino A., Giovagnoli Maria Rosaria, Ciliberto Gennaro
Primary Institution: Department of Clinical and Molecular Medicine, University of Rome “La Sapienza” S. Andrea Hospital, Rome, Italy
Hypothesis
Can malignant pleural effusions serve as a source for culturing cancer cells and studying their properties?
Conclusion
Malignant pleural effusions can efficiently propagate lung adenocarcinoma cells in vitro and in vivo, suggesting they are a valuable source for studying cancer stem cells.
Supporting Evidence
- Malignant pleural effusions can be cultured to grow lung cancer cells.
- Cells from pleural effusions showed efficient tumor engraftment in mice.
- Spheroid cultures had a higher percentage of cancer stem cell markers compared to adherent cultures.
- Gene expression profiles differed significantly between spheroid and adherent cultures.
- Primary cultures maintained viability and could be banked for further studies.
- Engrafted tumors in mice resembled the original human tumors histologically.
- ALDH1 activity was higher in spheroid cultures, indicating a greater presence of cancer stem cells.
- Statistical analysis showed significant differences in gene expression between culture types.
Takeaway
Doctors can grow cancer cells from fluid around the lungs to learn more about lung cancer and how to treat it.
Methodology
The study involved collecting malignant pleural effusions from lung adenocarcinoma patients, culturing the cells in different conditions, and analyzing their growth and characteristics.
Potential Biases
Potential bias in sample selection and the small sample size may affect the generalizability of the findings.
Limitations
The study focused on a limited number of samples and may not represent all lung adenocarcinoma cases.
Participant Demographics
Patients with lung adenocarcinoma, with ages ranging from 51 to 85 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website